TCG Crossover Management, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001839948 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 14, 2023

Total Value: $679M (100.0% shares, 0.0% debt)

Holdings (26)

GPCR STRUCTURE THERAPEUTICS INC 11.2%

Value $75.77M Shares 1,502,747 Share Price $50.42 Est. Cost/Share $44.22 Unrealized @ Report Date —

COGT COGENT BIOSCIENCES INC 8.1%

Value $54.9M Shares 5,631,042 Share Price $9.75 * Est. Cost/Share $9.54 Unrealized @ Report Date +24.3%

GERN GERON CORP 7.3%

Value $49.56M Shares 23,375,839 Share Price $2.12 * Est. Cost/Share $1.89 Unrealized @ Report Date +43.9%

ANTX AN2 Therapeutics, Inc. 6.3%

Value $43.07M Shares 2,678,209 Share Price $16.08 * Est. Cost/Share $9.33 Unrealized @ Report Date +21.3%

SVRA SAVARA INC. 5.6%

Value $37.8M Shares 10,000,000 Share Price $3.78 * Est. Cost/Share $3.56 Unrealized @ Report Date 0.0%

TSHA TAYSHA GENE THERAPIES, INC. 5.2%

Value $35.11M Shares 11,111,111 Share Price $3.16 * Est. Cost/Share $1.87 Unrealized @ Report Date 0.0%

KALV KALVISTA PHARMACEUTICALS, INC 4.8%

Value $32.7M Shares 3,395,495 Share Price $9.63 * Est. Cost/Share $5.36 Unrealized @ Report Date +90.7%

— INHIBRX,INC 4.7%

Value $32.12M Shares 1,750,387 Share Price $18.35 Est. Cost/Share $18.35 Unrealized @ Report Date —

— AEROVATE THERAPEUTICS INC 4.4%

Value $29.87M Shares 2,201,274 Share Price $13.57 Est. Cost/Share $15.75 Unrealized @ Report Date —

— Icosavax, Inc. 4.2%

Value $28.7M Shares 3,703,704 Share Price $7.75 Est. Cost/Share $9.93 Unrealized @ Report Date —

CMPS COMPASS PATHWAYS PLC 4.2%

Value $28.55M Shares 3,858,000 Share Price $7.40 Est. Cost/Share $7.40 Unrealized @ Report Date —

VTYX VENTYX BIOSCIENCES, INC 4.2%

Value $28.33M Shares 815,724 Share Price $34.73 Est. Cost/Share $29.94 Unrealized @ Report Date +15.5%

TYRA TYRA BIOSCIENCES INC 4.0%

Value $27.39M Shares 1,989,103 Share Price $13.77 * Est. Cost/Share $12.71 Unrealized @ Report Date +16.7%

MDGL MADRIGAL PHARMACEUTICALS INC 3.9%

Value $26.28M Shares 179,917 Share Price $146.04 * Est. Cost/Share $110.42 Unrealized @ Report Date +70.5%

SLN SILENCE THERAPEUTICS PLC 3.0%

Value $20.67M Shares 2,104,875 Share Price $9.82 Est. Cost/Share $10.03 Unrealized @ Report Date —

TARS TARSUS PHARMACEUTICALS, INC. 3.0%

Value $20.31M Shares 1,142,857 Share Price $17.77 Est. Cost/Share $17.70 Unrealized @ Report Date 0.0%

— RAYZEBIO, INC. 2.8%

Value $19.31M Shares 869,908 Share Price $22.20 Est. Cost/Share $22.20 Unrealized @ Report Date —

DYN DYNE THERAPEUTICS, INC 2.2%

Value $14.79M Shares 1,650,150 Share Price $8.96 * Est. Cost/Share $12.99 Unrealized @ Report Date -17.1%

CNTA CENTESSA PHARMACEUTICALS PLC 1.9%

Value $13.2M Shares 2,040,816 Share Price $6.47 Est. Cost/Share $6.47 Unrealized @ Report Date —

KURA KURA ONCOLOGY INC 1.9%

Value $12.98M Shares 1,423,642 Share Price $9.12 * Est. Cost/Share $14.54 Unrealized @ Report Date -30.2%

IMVT IMMUNOVANT, INC 1.9%

Value $12.86M Shares 334,853 Share Price $38.39 * Est. Cost/Share $12.59 Unrealized @ Report Date +79.5%

TRDA ENTRADA THERAPEUTICS INC 1.4%

Value $9.242M Shares 584,955 Share Price $15.80 Est. Cost/Share $17.12 Unrealized @ Report Date —

— GRACELL BIOTECHNOLOGIES INC. 1.3%

Value $8.752M Shares 3,038,889 Share Price $2.88 Est. Cost/Share $2.88 Unrealized @ Report Date —

CABA CABALETTA BIO, INC 1.1%

Value $7.409M Shares 486,795 Share Price $15.22 * Est. Cost/Share $3.64 Unrealized @ Report Date +275.3%

— MERUS N.V. 1.0%

Value $7.074M Shares 300,000 Share Price $23.58 Est. Cost/Share $30.46 Unrealized @ Report Date —

CCCC C4 THERAPEUTICS, INC. 0.3%

Value $2.374M Shares 1,276,574 Share Price $1.86 * Est. Cost/Share $5.83 Unrealized @ Report Date -47.7%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
GPCR	STRUCTURE THERAPEUTICS INC	1,502,747	$75.77M	11.2%	$50.42	$44.22	—	ADRS	86366E106
COGT	COGENT BIOSCIENCES INC	5,631,042	$54.9M	8.1%	$9.75 *	$9.54	+24.3%	COMM	19240Q201
GERN	GERON CORP	23,375,839	$49.56M	7.3%	$2.12 *	$1.89	+43.9%	COMM	374163103
ANTX	AN2 Therapeutics, Inc.	2,678,209	$43.07M	6.3%	$16.08 *	$9.33	+21.3%	COMM	037326105
SVRA	SAVARA INC.	10,000,000	$37.8M	5.6%	$3.78 *	$3.56	0.0%	COMM	805111101
TSHA	TAYSHA GENE THERAPIES, INC.	11,111,111	$35.11M	5.2%	$3.16 *	$1.87	0.0%	COMM	877619106
KALV	KALVISTA PHARMACEUTICALS, INC	3,395,495	$32.7M	4.8%	$9.63 *	$5.36	+90.7%	COMM	483497103
—	INHIBRX,INC	1,750,387	$32.12M	4.7%	$18.35	$18.35	—	COMM	45720L107
—	AEROVATE THERAPEUTICS INC	2,201,274	$29.87M	4.4%	$13.57	$15.75	—	COMM	008064107
—	Icosavax, Inc.	3,703,704	$28.7M	4.2%	$7.75	$9.93	—	COMM	45114M109
CMPS	COMPASS PATHWAYS PLC	3,858,000	$28.55M	4.2%	$7.40	$7.40	—	ADRS	20451W101
VTYX	VENTYX BIOSCIENCES, INC	815,724	$28.33M	4.2%	$34.73	$29.94	+15.5%	COMM	92332V107
TYRA	TYRA BIOSCIENCES INC	1,989,103	$27.39M	4.0%	$13.77 *	$12.71	+16.7%	COMM	90240B106
MDGL	MADRIGAL PHARMACEUTICALS INC	179,917	$26.28M	3.9%	$146.04 *	$110.42	+70.5%	COMM	558868105
SLN	SILENCE THERAPEUTICS PLC	2,104,875	$20.67M	3.0%	$9.82	$10.03	—	ADRS	82686Q101
TARS	TARSUS PHARMACEUTICALS, INC.	1,142,857	$20.31M	3.0%	$17.77	$17.70	0.0%	COMM	87650L103
—	RAYZEBIO, INC.	869,908	$19.31M	2.8%	$22.20	$22.20	—	COMM	75525N107
DYN	DYNE THERAPEUTICS, INC	1,650,150	$14.79M	2.2%	$8.96 *	$12.99	-17.1%	COMM	26818M108
CNTA	CENTESSA PHARMACEUTICALS PLC	2,040,816	$13.2M	1.9%	$6.47	$6.47	—	COMM	152309100
KURA	KURA ONCOLOGY INC	1,423,642	$12.98M	1.9%	$9.12 *	$14.54	-30.2%	COMM	50127T109
IMVT	IMMUNOVANT, INC	334,853	$12.86M	1.9%	$38.39 *	$12.59	+79.5%	COMM	45258J102
TRDA	ENTRADA THERAPEUTICS INC	584,955	$9.242M	1.4%	$15.80	$17.12	—	COMM	29384C108
—	GRACELL BIOTECHNOLOGIES INC.	3,038,889	$8.752M	1.3%	$2.88	$2.88	—	ADRS	38406L103
CABA	CABALETTA BIO, INC	486,795	$7.409M	1.1%	$15.22 *	$3.64	+275.3%	COMM	12674W109
—	MERUS N.V.	300,000	$7.074M	1.0%	$23.58	$30.46	—	COMM	N5749R100
CCCC	C4 THERAPEUTICS, INC.	1,276,574	$2.374M	0.3%	$1.86 *	$5.83	-47.7%	COMM	12529R107